thienocarbazoles derivatives (martin-luther-universitaet)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namethienocarbazoles derivatives (martin-luther-universitaet)
Drug Alias Namepyruvate kinase inhibitors (Martin-Luther-Universitaet)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase inhibitors
TargetsPyruvate kinase
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMartin Luther Christian University
China Registration ClassN/A

Develop Information

Active CompaniesMartin Luther Christian University
Inactive CompaniesN/A
Active IndicationsGram-Positive Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A